AbbVie Inc.

0QCV.IL·IOB·Healthcare
Compare
280.00−5.00 (−1.75%)today
At close: Oct 22, 4:54 PM BST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close285.00
Open281.00
Day range273.77293.00
52-week range186.49293.00
Off day high−4.44%
Off 52-week high−4.44%
Volume7.92K
Avg. volume (3M)14.93K
Market cap503.71B
EPS (TTM)4.86
Forward P/E—
P/E ratio (TTM)57.61
Dividend yield4.05% (5.92)
Beta (5Y)0.47
Shares outstanding1.77B
Short interest—
Earnings dateOct 30, 2026
Analyst target—
Profit margin15.50%

Against its peers

Compare in full ›
0QCV.IL BMY LLY BIIB AMGN PFE
Market cap 503.71B 128.69B 1.17T 37.51B 241.81B 173.38B
P/E (TTM) 57.6 13.9 43.9 45.1 27.8 40.0
Forward P/E — 9.5 27.7 15.4 18.3 10.5
Price/book 38.4 5.8 34.4 2.0 20.7 2.0
Dividend yield 4.05% 4.12% 0.54% — 2.30% 5.76%
1-year change +25.14% +39.45% +54.77% +60.57% +49.66% +21.00%
Today −1.75% +3.08% +2.83% +5.34% +2.04% +1.91%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

Latest news

All 0QCV.IL news ›
The Motley Fool·Positive

AbbVie vs. Bristol Myers Squibb: Faster Growth or Steady Revenue?

It completed the acquisition of Apogee Therapeutics to expand its dermatology and respiratory pipeline, and it secured regulatory approvals for multiple therapies in international markets. It secured accelerated regulatory approval for a…

Pharmaceutical Technology·Positive

AbbVie races into F1 as pharma companies continue push into sport

AbbVie is just one of several pharmaceutical companies to pen sponsorship deals in sport, blurring the commercial line between industries. AbbVie has continued its recent foray into sport by striking a partnership with Formula 1 (F1) team…

From articles in the 4Search news index.

In the news

205mentions in 30 days
205with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.